Literature DB >> 12791198

Urea Cycle Disorders.

Soledad Kleppe1, Asad Mian, Brendan Lee.   

Abstract

Urea cycle disorders comprise a group of inborn errors of metabolism that represent unique gene-nutrient interactions whose significant morbidity arises from acute and chronic neurotoxicity associated with often massive hyperammonemia. Current paradigms of treatment are focused on controlling the flux of nitrogen transfer through the hepatic urea cycle by a combination of dietary and pharmacologic approaches. Evolving paradigms include the development of cell and gene therapies. Current research is focused on understanding the pathophysiology of ammonia-mediated toxicity and prevention of neural injury.

Entities:  

Year:  2003        PMID: 12791198     DOI: 10.1007/s11940-003-0037-5

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  25 in total

Review 1.  Treatment of urea cycle disorders.

Authors:  J G Thoene
Journal:  J Pediatr       Date:  1999-03       Impact factor: 4.406

Review 2.  Role of glutamine in cerebral nitrogen metabolism and ammonia neurotoxicity.

Authors:  A J Cooper
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

3.  Psychosocial issues and coping strategies in families affected by urea cycle disorders.

Authors:  J A Cederbaum; C LeMons; M Rosen; M Ahrens; S Vonachen; S D Cederbaum
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

4.  The nutritional management of urea cycle disorders.

Authors:  J V Leonard
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

Review 5.  Alternative pathway therapy for urea cycle disorders: twenty years later.

Authors:  M L Batshaw; R B MacArthur; M Tuchman
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

Review 6.  Glutamine synthetase in brain: effect of ammonia.

Authors:  I Suárez; G Bodega; B Fernández
Journal:  Neurochem Int       Date:  2002 Aug-Sep       Impact factor: 3.921

7.  Loss of expression of glial fibrillary acidic protein in acute hyperammonemia.

Authors:  Mireille Bélanger; Paul Desjardins; Nicolas Chatauret; Roger F Butterworth
Journal:  Neurochem Int       Date:  2002 Aug-Sep       Impact factor: 3.921

8.  Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis.

Authors:  N E Maestri; D Clissold; S W Brusilow
Journal:  J Pediatr       Date:  1999-03       Impact factor: 4.406

Review 9.  Neurobiology of ammonia.

Authors:  Vicente Felipo; Roger F Butterworth
Journal:  Prog Neurobiol       Date:  2002-07       Impact factor: 11.685

10.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

View more
  8 in total

1.  Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency.

Authors:  Linda C Wendell; Amir Khan; Jonathan Raser; Shih-Shan Lang; Neil Malhotra; W Andrew Kofke; Peter LeRoux; Soojin Park; Joshua M Levine
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

2.  Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.

Authors:  Philippe M Campeau; Penelope J Pivalizza; Geoffrey Miller; Kim McBride; Saul Karpen; John Goss; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2010-02-19       Impact factor: 4.797

Review 3.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

4.  Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency.

Authors:  Ogee Mer Panlaqui; Khoa Tran; Amanda Johns; Jim McGill; Hayden White
Journal:  Intensive Care Med       Date:  2008-07-24       Impact factor: 17.440

5.  Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.

Authors:  Yudai Koya; Michihiko Shibata; Michio Senju; Yuichi Honma; Masaaki Hiura; Masahiro Ishii; Shirou Matsumoto; Masaru Harada
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

6.  Hyperammonaemic Encephalopathy Caused by Adult-Onset Ornithine Transcarbamylase Deficiency.

Authors:  Bjarke Hammer Niclasen; Maria Therese Schelde-Olesen; Mads Astvad; Anders Løkke; Thomas Krøigård; Helle H Nielsen
Journal:  Brain Sci       Date:  2022-02-08

7.  Acute Fulminant Encephalopathy in an Adult due to Ornithine Transcarbamylase Deficiency.

Authors:  Vivek K Nambiar; Aakash Shridharani; Sudheeran Kannoth; Siby Gopinath; Anand Kumar
Journal:  Ann Indian Acad Neurol       Date:  2022-08-04       Impact factor: 1.714

8.  Integrating cellular metabolism into a multiscale whole-body model.

Authors:  Markus Krauss; Stephan Schaller; Steffen Borchers; Rolf Findeisen; Jörg Lippert; Lars Kuepfer
Journal:  PLoS Comput Biol       Date:  2012-10-25       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.